271 related articles for article (PubMed ID: 20956182)
1. Mucoactive therapy in COPD.
Decramer M; Janssens W
Eur Respir Rev; 2010 Jun; 19(116):134-40. PubMed ID: 20956182
[TBL] [Abstract][Full Text] [Related]
2. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Sathananthan K; Fortescue R
Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
[TBL] [Abstract][Full Text] [Related]
3. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Chong J; Cates CJ
Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
[TBL] [Abstract][Full Text] [Related]
4. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
5. Mucoactive drugs.
Balsamo R; Lanata L; Egan CG
Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
[TBL] [Abstract][Full Text] [Related]
6. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Black PN
Cochrane Database Syst Rev; 2010 Feb; (2):CD001287. PubMed ID: 20166060
[TBL] [Abstract][Full Text] [Related]
7. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
Del Donno M; Olivieri D
Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
[TBL] [Abstract][Full Text] [Related]
8. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Black PN; Cates CJ
Cochrane Database Syst Rev; 2012 Aug; (8):CD001287. PubMed ID: 22895919
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Kew KM; Mavergames C; Walters JA
Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
[TBL] [Abstract][Full Text] [Related]
10. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
Zheng JP; Kang J; Huang SG; Chen P; Yao WZ; Yang L; Bai CX; Wang CZ; Wang C; Chen BY; Shi Y; Liu CT; Chen P; Li Q; Wang ZS; Huang YJ; Luo ZY; Chen FP; Yuan JZ; Yuan BT; Qian HP; Zhi RC; Zhong NS
Lancet; 2008 Jun; 371(9629):2013-8. PubMed ID: 18555912
[TBL] [Abstract][Full Text] [Related]
11. Mucoactive drugs for asthma and COPD: any place in therapy?
Rogers DF
Expert Opin Investig Drugs; 2002 Jan; 11(1):15-35. PubMed ID: 11772318
[TBL] [Abstract][Full Text] [Related]
12. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole PJ; Black PN
Cochrane Database Syst Rev; 2006 Jul; (3):CD001287. PubMed ID: 16855965
[TBL] [Abstract][Full Text] [Related]
13. Mucoactive drugs and multiple applications in pulmonary disease therapy.
Hocquigny A; Hugerot H; Ghanem R; Haute T; Laurent V; Cogulet V; Montier T
Eur J Pharm Biopharm; 2024 Jan; 194():110-117. PubMed ID: 38048888
[TBL] [Abstract][Full Text] [Related]
14. Clinical issues of mucus accumulation in COPD.
Ramos FL; Krahnke JS; Kim V
Int J Chron Obstruct Pulmon Dis; 2014; 9():139-50. PubMed ID: 24493923
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion.
Chakravorty I; Chahal K; Austin G
Int J Chron Obstruct Pulmon Dis; 2011; 6():693-9. PubMed ID: 22259246
[TBL] [Abstract][Full Text] [Related]
17. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
18. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
Janjua S; Fortescue R; Poole P
Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
Chong J; Karner C; Poole P
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]